Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Lilly“
Suchtreffer
Begriffe & Kennungen
Adcirca (previously Tadalafil Lilly) · 4.5 · P-glycoprotein substrates (e.g. digoxin) Tadalafil (40 mg once per day) had no clinically significant effect o
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Paediatric population
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Paediatric population
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Protease inhibitors (e.g. ritonavir) Ritonavir (200 mg twice daily), which is an inhibitor of CYP3A4, CYP2C9,
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Protease inhibitors (e.g. ritonavir) Ritonavir (200 mg twice daily), which is an inhibitor of CYP3A4, CYP2C9,
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Riociguat Preclinical studies showed an additive systemic blood pressure lowering effect when PDE5 inhibitors
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Riociguat Preclinical trials showed an additive systemic blood pressure lowering effect when PDE5 inhibitors w
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Terbutaline A similar increase in AUC and Cmax seen with ethinylestradiol may be expected with oral administra
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 Undesirable effects · 1
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 Undesirable effects · 2
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 10 were treated with placebo, for 24 weeks. The most common AEs, occurring in ≥ 2 patients treated with tadala
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 26 Respiratory, Nasopharyngitis Epistaxis thoracic and (including nasal mediastinal congestion, sinus disorder
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 27 weight cohort, ≥ 25 kg to < 40 kg) or 40 mg (heavy-weight cohort, ≥ 40 kg), and 18 patients were treated wi
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 8 In the pivotal placebo-controlled study of ADCIRCA for the treatment of PAH, a total of 323 patients were tr
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 9 Gastrointestinal Nausea, Vomiting, disorders Dyspepsia Gastroesophage (including al reflux abdominal pain/di
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · A total of 51 paediatric patients aged from 2.5 to 17 years with PAH were treated with tadalafil in clinical t
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · A total of 51 paediatric patients aged from 2.5 to 17 years with PAH were treated with tadalafil in clinical t
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Eye disorders Blurred vision Non-arteritic anterior ischemic optic neuropathy (NAION), Retinal vascular occlus
Eintrag öffnen